
Maximizing return on investments and managing to invest with assurance are things all investors, new and old, aspire to achieve.Regardless of what investing strategy you stick to, the Zacks Style Scores can simplify the process of discovering exceptional stocks. These are additional indicators that assess stocks on value, growth, and/or momentum.Is This 1 Momentum Stock a Screaming Buy Right Now?Momentum investors focus on the price and earnings trends for a stock and therefore need to pay close attention to the Momentum Style Score. This Score can also help identify optimal times to accumulate a stock, using the 1-week price change and several other indicators, including the monthly earnings estimate percentage change.Hims & Hers Health, Inc., based in San Francisco, CA, is a consumer-centric health and wellness platform that redefines healthcare with personalized and digitally accessible solutions. Founded in 2017, the company specializes in subscription services and retail partnerships, serving a wide spectrum of healthcare needs across major therapeutic areas. The company has a hybrid business model comprising of online subscription services and wholesale retail.HIMS is a Zacks Rank #1 (Strong Buy) stock, with a Momentum Style Score of B and VGM Score of B. HIMS is down 8.5% over the past one week and up 13.4% over the past four weeks. HIMS has also gained 134% in the last one year period. In terms of trading volume, the stock has had an average of 33,722,048 shares traded daily over the last 20 trading days.For momentum investors, just the price movement is not enough, positive earnings, has to be in the picture too. In the last 60 days, one of the analysts has increased their earnings estimate for HIMS for fiscal 2025. The Zacks Consensus Estimate has increased by $0.02 to $0.75. The average surprise for earnings also sits at 19.6% for HIMS.Considering the strong earnings growth, a good Zacks Rank, plus the added top tier scores for Momentum and VGM style, investors looking to diversify might want to add HIMS to their holdings.Zacks Investment Research is always looking for the next great investment opportunity, so if you're interested in holding their 7 best stock recs for the next 30 days, Zacks has you covered.
Around the web